Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | ||
Ligand | BDBM50433030 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_955790 (CHEMBL2379607) | ||
Ki | 2.4±n/a nM | ||
Citation | Cheng, H; Hoffman, JE; Le, PT; Pairish, M; Kania, R; Farrell, W; Bagrodia, S; Yuan, J; Sun, S; Zhang, E; Xiang, C; Dalvie, D; Rahavendran, SV Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series. Bioorg Med Chem Lett23:2787-92 (2013) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | |||
Name: | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | ||
Synonyms: | PI3-kinase p110 subunit alpha | PI3-kinase p110-alpha subunit | PI3K | PK3CA_MOUSE | Phosphatidylinositol 3-kinase p110α (p110α) | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3K alpha) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Pik3ca | PtdIns-3-kinase p110 | ||
Type: | Protein | ||
Mol. Mass.: | 124421.84 | ||
Organism: | Mus musculus (Mouse) | ||
Description: | P42337 | ||
Residue: | 1068 | ||
Sequence: |
| ||
BDBM50433030 | |||
n/a | |||
Name | BDBM50433030 | ||
Synonyms: | CHEMBL2376093 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H24N6O4 | ||
Mol. Mass. | 412.4424 | ||
SMILES | COc1ncc(cn1)-c1cc2c(C)nc(N)nc2n([C@@H]2CC[C@@H](CC2)OCO)c1=O |r,wD:19.20,22.27,(52.42,-2.69,;51.08,-1.92,;49.75,-2.69,;49.75,-4.23,;48.41,-4.99,;47.08,-4.21,;47.08,-2.68,;48.41,-1.91,;45.74,-4.97,;44.39,-4.19,;43.06,-4.97,;41.72,-4.21,;41.72,-2.67,;40.39,-4.98,;40.39,-6.52,;39.06,-7.29,;41.72,-7.29,;43.05,-6.52,;44.39,-7.3,;44.38,-8.84,;45.71,-9.6,;45.7,-11.15,;44.36,-11.91,;43.04,-11.13,;43.04,-9.6,;44.35,-13.45,;43.01,-14.21,;41.69,-13.43,;45.74,-6.53,;47.07,-7.3,)| | ||
Structure |